Search

everythinglearnresearchcommunity

for

Search:↓

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

ITK inhibitors may effectively treat alopecia areata.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Lichen Planopilaris causes irreversible hair loss due to immune attacks on hair stem cells, but modulating PPAR-γ might help treat it.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

Terbinafine can cause skin reactions when exposed to sunlight, so sun exposure should be avoided during treatment.

Linalool in fragrances may harm hair follicles and contribute to hair loss.

Substance P may play a role in the inflammation seen in keratosis follicularis spinulosa decalvans.

Lower MC2R expression may contribute to alopecia areata.

88% phenol is effective for treating alopecia areata.

Being allergic to linalool, a common fragrance ingredient, might contribute to developing frontal fibrosing alopecia.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Poor blood supply in hair follicles is linked to nutrient deficiency in patients with female pattern hair loss, and adding more nutrients could potentially fix this.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

AFM can help diagnose lichen planopilaris by identifying specific hair structure changes.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.